NCT04461002View on ClinicalTrials.gov

Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Glioma
Interventions
OTHER

Retrospective analysis

Evaluate the correlation between tumour molecular profile and preoperative imaging data (FDG and FDOPA PET-scan and multimodal MRI).

Trial Locations (1)

13009

Hôpital Privé Clairval, Marseille

All Listed Sponsors
lead

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

NCT04461002 - Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas. | Biotech Hunter | Biotech Hunter